Light Mode
$151.91 ↑ +0.00 (+0.00%) Trading Up from the previous close of $151.91, $0.61 below the day’s high of $152.52
+1.13 (+0.79%) / 6M
Momentum, market sentiment, and recent alerts
UCBJY reads very good: price sits above both the 20- and 200-day averages, the 12-month move is +0.8%.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
UCB SA engages in the research and development of biopharmaceuticals products. It offers medicinal products such as briviact, keppra, vimpat, neupro, cimzia, nootropil, xyrem, xyzal, and zyrtec. The company was founded by Emmanuel Janssen on January 18, 1928 and is headquartered in Brussels, Belgium.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.